Patents Assigned to FuturaGene Israel, Ltd.
-
Patent number: 11555195Abstract: Constructs for genetically engineering plants to selectively alter DELLA gene expression to promote plant growth while maintaining root integrity are provided, as are methods of designing, making and using such constructs.Type: GrantFiled: September 17, 2018Date of Patent: January 17, 2023Assignee: Futuragene Israel Ltd.Inventors: Miron Abramson, Tany Sinai, Sivan Livne
-
Patent number: 10407692Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.Type: GrantFiled: May 28, 2017Date of Patent: September 10, 2019Assignee: Futuragene Israel Ltd.Inventors: Hanan Stein, Dror Avisar
-
Patent number: 10155959Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.Type: GrantFiled: April 19, 2013Date of Patent: December 18, 2018Assignee: Futuragene Israel Ltd.Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
-
Patent number: 10011846Abstract: The present invention provides a bio-fuel, wood or other product, such as a paper, textile or yarn product. The product can contain material from a transgenic plant over-expressing a nucleic acid molecule encoding an enzyme that causes the plant cell wall to be more water soluble than the wild type.Type: GrantFiled: March 26, 2008Date of Patent: July 3, 2018Assignees: Futuragene Israel Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Inventors: Oded Shoseyov, Ziv Shani, Miron Abramson
-
Patent number: 9970022Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.Type: GrantFiled: March 30, 2012Date of Patent: May 15, 2018Assignee: Futuragene Israel Ltd.Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
-
Patent number: 9856492Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.Type: GrantFiled: March 1, 2012Date of Patent: January 2, 2018Assignee: Futuragene Israel Ltd.Inventors: Hanan Stein, Dror Avisar
-
Publication number: 20170260542Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.Type: ApplicationFiled: May 28, 2017Publication date: September 14, 2017Applicant: Futuragene Israel Ltd.Inventors: Hanan STEIN, Dror AVISAR
-
Publication number: 20150259701Abstract: The present invention relates to the field of doublestranded RNA (dsRNA)-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.Type: ApplicationFiled: October 2, 2013Publication date: September 17, 2015Applicant: Futuragene Israel Ltd.Inventor: Dror Avisar
-
Publication number: 20150082482Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.Type: ApplicationFiled: April 19, 2013Publication date: March 19, 2015Applicant: Futuragene Israel Ltd.Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
-
Publication number: 20140157455Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.Type: ApplicationFiled: March 30, 2012Publication date: June 5, 2014Applicant: FUTURAGENE ISRAEL LTD.Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
-
Publication number: 20130347141Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.Type: ApplicationFiled: March 1, 2012Publication date: December 26, 2013Applicant: FUTURAGENE ISRAEL LTD.Inventors: Hanan Stein, Dror Avisar
-
Publication number: 20130097731Abstract: An isolated polynucleotide is disclosed comprising: (i) a nucleic acid sequence encoding at least one toxic peptide, the toxic peptide being a spider toxin; and (ii) a nucleic acid sequence encoding a chitinase attached to a secretion signal sequence. Uses thereof and plants expressing same are also disclosed.Type: ApplicationFiled: June 16, 2011Publication date: April 18, 2013Applicant: Futuragene Israel Ltd.Inventors: Dror Avisar, Hanan Stein, Ziv Shani
-
Patent number: 8013211Abstract: The invention relates to stinging cells or isolated capsules and to their use in compositions and methods for efficient delivery of biologically active agents into a plant cell or plant tissue. The biologically active agent to be delivered by the methods of the present invention is selected from a nucleic acid, a peptide, a polypeptide, a plant hormone, an enzyme, an herbicidal agent, an anti-viral agent, an anti-bacterial agent and an anti-fungal agent. Particularly, the invention is related to compositions and methods for the efficient transformation of polynucleotide construct into a plant cell or tissue, to obtain transgenic plants.Type: GrantFiled: July 5, 2006Date of Patent: September 6, 2011Assignee: FuturaGene Israel, Ltd.Inventor: Ziv Shani